BioAtla, Inc.
BCAB
$4.54
$0.020.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -81.82% | -100.00% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -81.82% | -100.00% | -- | -- | -- |
| Cost of Revenue | -30.94% | -36.28% | -37.20% | -43.90% | -39.17% |
| Gross Profit | 20.20% | 25.18% | 49.97% | 54.80% | 49.78% |
| SG&A Expenses | -18.84% | -17.52% | -13.29% | -11.62% | -15.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.83% | -31.82% | -32.01% | -37.63% | -34.50% |
| Operating Income | 19.80% | 23.12% | 42.01% | 46.41% | 42.98% |
| Income Before Tax | 14.57% | 20.91% | 43.08% | 48.11% | 43.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.57% | 20.91% | 43.08% | 48.11% | 43.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.57% | 20.91% | 43.08% | 48.11% | 43.48% |
| EBIT | 19.80% | 23.12% | 42.01% | 46.41% | 42.98% |
| EBITDA | 19.29% | 22.85% | 42.12% | 46.61% | 43.16% |
| EPS Basic | 29.44% | 32.28% | 49.41% | 51.05% | 44.32% |
| Normalized Basic EPS | 29.44% | 32.28% | 49.41% | 51.05% | 44.32% |
| EPS Diluted | 29.44% | 32.28% | 49.41% | 51.05% | 44.32% |
| Normalized Diluted EPS | 29.44% | 32.28% | 49.41% | 51.05% | 44.32% |
| Average Basic Shares Outstanding | 21.11% | 16.89% | 11.77% | 6.70% | 1.66% |
| Average Diluted Shares Outstanding | 21.11% | 16.89% | 11.77% | 6.70% | 1.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |